LEGN
Legend Biotech Corporation
Latest News for LEGN
RBC Capital analyst Leonid Timashev maintained a Buy rating on Legend Biotech on April 7 and set a price target of $62.00. The company’s shares clo......
Legend Biotech Corporation (($LEGN)) has held its Q4 earnings call. Read on for the main highlights of the call. Legend Biotech’s latest earnings c......
In a report released yesterday, Rishi Jaluria from RBC Capital maintained a Buy rating on Legend Biotech, with a price target of $62.00. The compan......
In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Legend Biotech, with a price target of $78.00. Tenthoff c......
News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LEGN | $18.30 | 0% | 2.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Legend Biotech Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW